(АРЭ) у здоровых людей и больных, патологические изменения у которых вызваны. 5 Известно несколько способов оценки АРЭ: а) по изменению скорости оседания эритроцитов по Панченкову Т.П. под.


Чтобы посмотреть этот PDF файл с форматированием и разметкой, скачайте его и откройте на своем компьютере.
!"##$%#&'()*+*!',$(
)*+*!'-./'(#-012'
3"$/4*--*&40'-./"%#"2#45*//"#4$
(51)
63&
G01N33/48
(2006.01)
G01N33/52
(2006.01)
(19)
(11)
2471189
(13)
(12)
"3$#'/$*$7"2!*4*/$(&3'4*/40
(21)(22)
789:;8
2011122065/15, 31.05.2011
(24)
+88=8&#x-36.;h-2;V.6;&#x=-8.;h-0;&#x.400;[email protected]&#x-12.;⨀[email protected];8DBEA:F9G8B=8
31.05.2011
[email protected]
(22)
[email protected]&#x-208;&#x-240;&#[email protected];&#x.2D8;.2;FI89:;F
31.05.2011
(45)
"GJK?F;@:[email protected]
27.12.2012
2L?
(56)
#[email protected];[email protected];[email protected]:
[email protected]:8==HP:@Ȳ.; [email protected]
[email protected];B
,$!&$/5
FDC
"OB=;8KB8
[email protected];F:[email protected]@[email protected]:J
[email protected]=UF=
)[email protected][email protected]
[email protected]:B;8
. - 1998,
.134-142. RU 2138805
C1, 27.09.1999. RU 2120632 C1, 20.10.1998. RU
2026552 C1, 09.01.1995. RU 96120794 A,
10.11.1998. RU 2375071 C1, 10.12.2009.
(54)
#3"#"2",*/&$'+!*/"!*'&4$5/"#4$[!$4!",$4"5
(57)
!BWBC8
[email protected][email protected][email protected];@[email protected][email protected]
FNBDFOF=H
#[email protected]@[email protected]=;F
[email protected];F:[email protected]@[email protected]:[email protected]:@[email protected]
FINB=B=FLA;@[email protected]@[email protected]@:
#"[
[email protected]:FBN8DCB=8?F=8
in vitro
;@=OB=C8OF9P
[email protected]?T
?:[email protected][email protected];[email protected]:F�[email protected]:B;[email protected]=B
[email protected];8DHFP
[email protected]@[email protected]:@[email protected]
[email protected]:?9BNHN:FAA?BDJBNJLOFC8=JL
:[email protected]=JL;[email protected]:T
[email protected][email protected]=8
[email protected]:?9B
[email protected]?T
5HDB?9LC8I?&#x-575;&#x.6C1;.98;4.1;&#xI?-9;&#x.1F0;F=HB
[email protected]:8=F9:I8:[email protected]@
=8GC8:[email protected]@;[email protected]=B=FE#"[@
[email protected][email protected]@[email protected]:=9
:[email protected]@[email protected]:HZB=F9
;8;
[email protected]==HE
A=FXB=F9
;8;
[email protected]==HE
[email protected]:[email protected]@
@;[email protected]=B=F9
;8;8CB8;F:=HE
�!8AAFH:8L
;@?F�BA:[email protected]=;JFINB=B=FE
[email protected];F:[email protected]@[email protected]::
[email protected][email protected];[email protected]=B=F9#"[@
[email protected][email protected]@I=8�B=F9
GCBDA8:?B==JL::FDB
ACBD=FPI=8�B=FE'![
ACBD=FBI=8�B=F9'![
C8AA�FH:[email protected]:FS8N:@:[email protected]=B
;@=OB=C8OFE8DCB=8?F=8
"OB=;8
WJ=;[email protected][email protected]@[email protected]@[email protected]@:
[email protected]:@[email protected]=F:[email protected]'![A
[email protected]=8;8
G?LAGCFA=FXB=FF:B?F�F=H
,NF=JAGCFJ:B?F�B=FF
[email protected][email protected]@:8=FB
[email protected]:[email protected];[email protected]@:
[email protected]@[email protected]:@OB=F:[email protected][email protected]
NBXDJ;@[email protected][email protected]@[email protected]:
GCFAJA:[email protected]:[email protected]=8
#[email protected]@K
[email protected]:@?9B:H9:FTSCJGGJ?FO
[email protected][email protected]
[email protected]@K=HP;C8I:[email protected][email protected];OFFF
.: 1
RU2471189C1
[email protected][email protected]@:8T?B&#x-26.;T-3;w.8;&#x?-33;&#x.8B8;&#x.400;BK=HEYWWB;[email protected]@:
[email protected]?B:8=F9NFABCDB�[email protected]
[email protected]@E
AFABNH
(56)(
[email protected]@?XB=FB
2-adrenergic receptors with th
ase system//Mol. Pharmacol. - 1983, v.24(2), p.174-82,
CBWBC8
.: 2
RU2471189C1
RUSSIAN FEDERATION
FEDERAL SERVICE
FOR INTELLECTUAL PROPERTY
(51)Int. Cl.
G01N33/48
(2006.01)
G01N33/52
(2006.01)
(19)
(11)
2471189
(13)
(12)
ABSTRACT OF INVENTION
(21)(22)Application:
2011122065/15, 31.05.2011
(24)Effective date for property rights:
31.05.2011
Priority:
(22)Date of filing:
31.05.2011
(45)Date of publication:
27.12.2012Bull.36
Mail address:
450074, g.Ufa, ul. Z. Validi, 32, GOU VPO
BashGU, Nachal'niku
patentnogo otdela, G.S.
Shangaraevoj
(72)Inventor(s):
Shamratova Valen
tina Gusmanovna (RU)
Khazipova Inna
Ramilevna (RU)
Bagautdinova Ramilja Shamilevna (RU)
(73)Proprietor(s):
Gosudarstvennoe obrazova
tel'noe uc
"Bashkirskij gosudarstve
(54)
RU2471189C1
RU2471189C1
[email protected][email protected][email protected];@[email protected][email protected]=H
[email protected][email protected]
[email protected]
[email protected][email protected]:[email protected]?9;@?F.6T;&#x-283;&#x.7F1;.8A;�.3G;&#x-5.5;&#[email protected];&#x?10.;T-1;.2I; .1;&#[email protected];&#x:8=-;.7;&#[email protected];.3D;.6;&#x?9-2;F.8;&#x;@?F;.60;BA:[email protected]@OB=;[email protected];F:[email protected]@[email protected]:
)[email protected]@:[email protected]?T=HP
[email protected][email protected]&#[email protected];&#x-6?2;&#[email protected];&#x-6S-;.9;ù.9;BA;FBFINB=B=F9J;@@CHP:HI:8=H
[email protected]:[email protected];F:[email protected][email protected]&#x-1.4;&#xT-6.;L-2;f.2;跁.4B;.7;&#x=-14;&#[email protected];.4Y;&#x-12C;.1S;&#x-14F;.80;BA;[email protected]::BSB8F:[email protected]?9OFF
$I:[email protected]=BA;@?T;@[email protected]@[email protected]:@OB=;F'![
[email protected]=B=FLA;@[email protected]@[email protected]@:[email protected]=&#x-6.9;&#[email protected];:-2;X.6;&#[email protected];G.4;㠗&#x.1=-; .80;B=;@:J4
[email protected]
:?F9=FBN
in vitro
[email protected][email protected];[email protected]
[email protected][email protected][email protected]?8:[email protected]=B;@[email protected]
G8B=!)
2120632,
. G01N 33/48, G01N 15/05,
@GJK?
I8:[email protected]@ABGB=F:[email protected][email protected][email protected]'![::[email protected][email protected];[email protected]:F
8:@CH:HDB?9?FA?BDJLUFB:[email protected]:[email protected];@[email protected]@[email protected]@:
#"[
): 60-80%
@;@[email protected][email protected]@[email protected]:=9
JNBCB==89
[email protected]?T=89
[email protected]?BB
80% -
A=FXB==89
8NB=BB
60% -
[email protected]:HZB==89
[email protected]@D8:@C8NFKH?
[email protected]@:8=
[email protected]==HE:[email protected];[email protected][email protected][email protected]:8=FB
;[email protected];[email protected]:F
[email protected][email protected][email protected][email protected]?T;@:@[email protected];@=OB=C8OFF
C8:[email protected]
[email protected]==HE$
[email protected][email protected]:@[email protected]:[email protected]:H9:?B=F9
[email protected];F:[email protected]@[email protected]:[email protected][email protected]:;F=BF;FFP;[email protected][email protected]@
[email protected]?FI8GCF:=BAB=FF:[email protected];[email protected]:[email protected][email protected][email protected]?8
[email protected];[email protected]
�@CB8;OF9=8
[email protected][email protected][email protected]?C8I?F�[email protected]?8D8=FBN8DCB=YCSF&#x-3.5; -10;&#x.89-;ɗ.; J-2;e.4;&#x?-10;&#x.7FO;&#x-288;&#x.8A-;ɕ.; G-2;.8C; -10;&#[email protected];&#x-9.1;&#x?8-2;�.3D;-20;&#x.3=-;.4F;&#x-13.;{N-;ʃ.;ƍ-; .7C;&#x-9.2; -0.;=-1;.6Y;&#x-24.;<S-;&.3;-13;&#x.700;BA;@[email protected]?F
[email protected]?F=Y�CSFBA;@[email protected]:B=TB::BSB8F:[email protected]?9OFF
I8:[email protected]:@[email protected]?8
[email protected]?B=D8$
[email protected]?B=D8'
6FDC
&F=BFBA;[email protected]@[email protected]:8=F9
[email protected]@[email protected]::[email protected]
)[email protected][email protected][email protected]:B;8
. 1994.
.20,
.151-155;
$:[email protected]:5
[email protected]?B=D8$
[email protected]=89DF=8NF;8;8CF=H;[email protected]:FF;[email protected][email protected]@
[email protected][email protected]==HN8:@[email protected]:[email protected]@Y;AGCBAA
8=8?FI8:[email protected]:F9PS
[email protected]:@
)[email protected][email protected][email protected]:B;8
. 1996.
.22,
.76-81;
[email protected]?B=D8$
&8IF=[
FDC
[email protected];
:[email protected]:9IBENBXDJG8C8NBC8NF;F=BF;F;[email protected][email protected]@[email protected][email protected]@:F
WJ=;[email protected][email protected]@[email protected]=FIN8
)[email protected][email protected][email protected]:B;8
. 1996.
.22,
.130-
136).
@[email protected]:[email protected][email protected]@F&#x-14F;.40;BA;@[email protected]@[email protected]:[email protected]=B
DBEA:F98DCB=YCS&#x-11.;:12;&#x.5F9;&#x-245;&#x.58-;.9D;.9;쬑&#x.8=-;.4;&#xY8.6; -7S;&#x-3.7;FBA;FPACBDA:
#@NF=A;FE5
";J=T&
#B:[email protected]:8/
[email protected]:[email protected]@F".6;༒.;оBA;@[email protected]@[email protected]:[email protected]:[email protected][email protected][email protected]?8
[email protected]@[email protected][email protected]
. 1981,
.525-527).
#@[email protected]==HNYFP8:@[email protected]:
[email protected]÷.5;BA;FBACBDA:8
8DCB=8?F=
8?JGB=
A:9IH:89ATA
[email protected]@[email protected]@:&#[email protected];&#x:-26;.60;[email protected]:B;8
in vitro,
[email protected]@F&#x-23.;?-1;.10;BA;JL
[email protected]
[email protected][email protected];[email protected]@[email protected][email protected][email protected];FCJBYWWB;H8DCB=8?F=8F
F=:BCFCJBDBEA:FB8?JGB=8
@[email protected]:[email protected]@;8IH:89:[email protected]@KA:[email protected]
:[email protected]@&#x-12.;开FBA;[email protected]@[email protected]:
[email protected]:HZ89BB
':@[email protected]
@K=8CJXF?F:@[email protected];F:[email protected]=W8C;[email protected];8CD8
"[email protected]
A:FDBB?TA:[email protected];
�@[email protected]:[email protected]@F.5F;&#x-1.7;BA;@[email protected]@[email protected]:
[email protected]:[email protected][email protected][email protected][email protected]?T=HPF=W8C;@[email protected];[email protected]@?BB
AJUBA:B==HN
[email protected]@:HP
#@NF=A;FE5
2BCDHZB:8-
2?JN8!
&8?=F=9$
.,";J=T&
#B?F:[email protected]:8V
68=JPF=2
[email protected][email protected]:8=FB
[email protected]@:[email protected]@OB=;FWJ=;[email protected][email protected]@[email protected]@9=F9
[email protected]@[email protected]:
)[email protected]?�@SFBA;FEXJC=8?###!
. 1989.
.75,
.189-193).
"D=8;@[email protected]@[email protected];F
[email protected][email protected];?F=F&#xT-29;.3;;&#x-4?-; .2F;&#x-2=-;.1;-20;BA;@[email protected]=;F
[email protected]@[email protected][email protected]@@[email protected]@:8=F9
)[&
-56
[email protected]
[email protected]@==HE:AC9PF:8B?T
OB=CFWJS8
@AJA:[email protected]:=HPI=8&#x-11F;&#x:-17;&#x.6=H;&#x-13P;&#x-272;&#x.9I1;&#x.5=-;.9;-7.;оB=FE
[email protected]:@C&#x-1.4;ø.8;&#x:[email protected];ఓ.;䬀BFD8==HN8=8?FI8;[email protected][email protected][email protected]
[email protected]?B=D8$
[email protected]?B=D8
A.M.,
V8??BB:'
$:[email protected]:5
/F;J?F=84
&F=BFBA;[email protected]@K
.: 4
15
20
25
30
35
40
45
50
RU2471189C1
[email protected]:[email protected]@[email protected]::[email protected]
)[email protected][email protected][email protected]:B;8
. 1994.
.20.
.151-155).
[email protected]?BBK?FI;[email protected]=F&#x-12.;{P-; .1=;&#x-15.;o-1;.70;BA;@[email protected]:[email protected]@[email protected]=;F
[email protected];F:[email protected]@[email protected]:[email protected]=B=FLA;@[email protected]@[email protected]@:
;[email protected];[email protected]:F
G8B=!)
2138805,
. G01N 33/48,
@GJK?
@[email protected]@38=�B=;@:J4
[email protected]:?F9=FBN
[email protected][email protected];[email protected]@KIFD8=8
[email protected]:[email protected]@
in vitro
:FAA?BDJBNJLOFC8=JL;[email protected]:T
[email protected]:FF
�@[email protected]=89
#"[:HZB
[email protected]?TIJL;8GF??9C=JL;[email protected]:TF
[email protected]:FAFNJL
#"[@GCBDB?9L:GCFAJA:[email protected][email protected];@[email protected]=8
3CF
[email protected][email protected][email protected];F:[email protected]@[email protected]:[email protected]:[email protected]=8GCF:@DF;
A=FXB=FL#"[
3CF
[email protected]:[email protected]#"[
[email protected]:?9LUBE
85-95%
@;@[email protected][email protected]
:B?F�F=H#"[
[email protected];F:[email protected]@[email protected]:@OB=F:8BA9;8;JNBCB==89
[email protected]?T=89
[email protected]?BB
95% -
;8;A=FXB==89
8NB=BB
85% -
;8;[email protected]:HZB==89
#[email protected]@K
[email protected][email protected];[email protected]
[email protected]:[email protected]@:
:[email protected]
[email protected]=BF&#x-12.;_-2;&#x.300;BA;@[email protected]?B&#x-12.;_-2;&#x.300;B=F9F;@[email protected][email protected];F:[email protected]
0;[email protected]
[email protected]:@[email protected][email protected]@:[email protected]@CS8=FIN8;[email protected]
[email protected][email protected]@:8T&#x-3.1;뀀BB=FB
[email protected]@:@[email protected];[email protected]@:8TSCJGGJCFA;[email protected]:[email protected]@[email protected]:@E
[email protected]
3CBFNJUBA:[email protected]@[email protected]@K89:[email protected]@8:[email protected]?=B=F9
[email protected]@K\B;F:[email protected]
[email protected][email protected]:8=FB;[email protected];[email protected]:F
#[email protected]@K=BCBKJB
[email protected]@@[email protected]@:8=F9FCB8;F:@:
�@[email protected]@AJG=HND?9GCFNB=B=F9:
[email protected];@E;?F=F�BA;@EGC8;F;B
[email protected]@F=A:@[email protected]@[email protected]@K89:?9BA9
[email protected]@?.88;&#x-275;&#x.5G-;&#[email protected];&#x?9.8;&#xJ000;[email protected]:
:Bɡ.;鬨.20;B=FB
�8A8
�@[email protected]:@?9B
�:[email protected]
[email protected][email protected]:[email protected][email protected]?B=F98;F;F:[email protected]@:
/[email protected];@[email protected]@[email protected]:[email protected]
�@@[email protected][email protected]:[email protected];J
[email protected];F:[email protected]@?T;@[email protected][email protected][email protected]=8GC8:?B==8C8==LL
[email protected];[email protected]=F9C8I:[email protected]@[email protected]:[email protected][email protected]=F&#x-3.2;఑.;&#[email protected];N-7;&#x.2K1;&#[email protected];&#xI9.3;&#[email protected]:-2;T.9;&#xJ-27;.3C;.6;&#[email protected]=;&#x-6.1;÷O-;ɨ.;-2;X.5;&#[email protected];&#xS-5.;\-8;&#x.981;�.6=;&#x-16.;㽰B=:
[email protected][email protected]:[email protected]@:HP?LDBE
[email protected]:BDB==HB=8NF:Bଐ.; B=FB
[email protected]:8=F9=8:[email protected];[email protected]?BB&#x-277;&#x.4F-;ኡ.3A;&#x-9.1;&#[email protected];&#x-7.5;&#x:-18;&#x.68-;.4=;&#x-14.;Ÿ-1;&#x.89-;ɦ.;=-1;.98;&#x-273;&#x.9:-;.4H;&#xK-17;&#[email protected];&#x-7.5;&#x;B-2;d.4;&#xK-7.;&#[email protected];&#x.5?1;&#x.2B-; .1B;&#x-254;&#x.200;BN
500
[email protected]:B;
[email protected];8I8?F
�@[email protected]@:HP?LDBEGCF:@IDBEA:[email protected]
in vitro
8DCB=8?F=8:
[email protected]@
[email protected]?T
?:H9:[email protected]=8GC8:?B==HBFINB=B=F9#"[[email protected]
ABGB=F:[email protected]
78D8�[email protected]:?9BA9:@[email protected][email protected]@[email protected]:[email protected]
;@?F�BA:[email protected]@OB=;[email protected];F:[email protected]@[email protected]:D?9
FI�JB=F9
[email protected][email protected]�BA;@[email protected]@:[email protected]@:[email protected]@:HP?LDBE
F:GBC:[email protected]�BCBDTJ
8;;8;I=8&#x-11.;᠒&#x.9;-;ɨ.;7.;8-7;&#x.5;-;ɘ.;I11;&#x.6=6;&#x.48-;.50;B=F9#"[[email protected]:8=H:B?ﰓ&#[email protected]:;-7.;=6.;H-2;h.4;&#x:2.7;଒.;?12;&#x.3F0;[email protected]
[email protected][email protected]@:[email protected]@&#[email protected];EF:@[email protected]=FIN8AOB?TLGCBDJGCBXDB=F9ACH:8:
[email protected]&#x-1.3;-11;&#x.500;BA;@[email protected]=OF8?B
:H9:?B=F9SCJGGH?FO
[email protected][email protected]@[email protected]=HP;
C8I:[email protected][email protected];OFF
[email protected][email protected]:8=FB8;@[email protected]@[email protected]@[email protected];8I8TA9
[email protected][email protected][email protected]:
J�8A:JLUFP:[email protected]:[email protected]=F9P
[email protected]:
AD8LUFPY;I8NB=H
[email protected][email protected]@:8=F9?B�[email protected]@YWWB;[email protected]@:J?LDBEA
[email protected]?B:8=F9NFABCDB�[email protected]
[email protected]@EAFABNH
,[email protected]@[email protected]=F9
[email protected];[email protected]@K8;@?&#x-13.;-5;&#x.38-;ʅ.;ک.;G-2;&#[email protected]; -10;&#[email protected];&#x-19.;(-2;e.2;&#x;-15;&#[email protected]; ?-0;&#x.3F0;FBA:[email protected]@OB=;F
[email protected];F:[email protected]@[email protected]:
88;[email protected]@[email protected]:[email protected]=8GC8:[email protected]
;@?BK8=FE#"[
[email protected]:[email protected]:[email protected]@[email protected]@OB=;F
[email protected];F:[email protected]@[email protected]:[email protected]=B=FLA;@[email protected]@[email protected]@:[email protected]
DBEA:FBN8DCB=8?F=8
in vitro
:;@=OB=C8OF9P
[email protected]?T
:[email protected][email protected];[email protected]:F�[email protected]:B;[email protected][email protected];8DHFP
[email protected]@[email protected]:@[email protected]
.: 5
RU2471189C1
[email protected]:[email protected]@:FAA?BDJBNJLOFC8=JL:[email protected]=JL;[email protected]:T
GCF�BN;@=OB=C8OF9
@[email protected]:?9B
[email protected]?T
:HDB?9LC8I?&#x-265;&#x.8C8;&#xI12.;?12;&#x.8F0;[email protected]:8=F9:
I8:[email protected]@=8GC8:[email protected]@;[email protected]=B=FE#"[@[email protected][email protected]@[email protected]:=9
:[email protected]@=J
[email protected]:HZB=F9
;8;[email protected]==HE
A=FXB=F9
;8;[email protected]==HE
[email protected]:FF
[email protected]@@;[email protected]=B=F9
;8;8CB8;F:=HE
C8AA�FH:8L;@?F&#x-278;&#x.8;-;&#[email protected];&#x-8.9;&#x?F-1;.40;BA:[email protected]=;J
[email protected];F:[email protected]@[email protected]::[email protected][email protected];[email protected]=B=F9#"[
@[email protected][email protected]@I=8&#x-279;&#x.1FA;&#x-10.;&#[email protected]; .2D;&#x=-26;&#[email protected];&#x-26.;&#[email protected];t.6;&#xI-1.;=-6;&#x.48-; .3;B=F9
GCBDA8:?B==JL::FDBACBD=FPI=8.6;:7?;.6;¶.3;&#x==J7;&#xL-26;.4:;&#x-258;&#x.5:7;ó.4;ഗ.;k-2;䦡.5C;.9B;.5;×.4;&#x=10.;߳.;P-2;X.5;&#xI15.; =87;B=FE'![
ACBD=FB
I=8�B=F9'![C8AA�FH:[email protected]@;[email protected]=B=F9N:@:[email protected]=B;@=OB=C8OFE
8DCB=8?F=8
@OB=;8WJ=;[email protected][email protected]@[email protected]@[email protected]@:[email protected]:@[email protected]=F
:[email protected]'![AJ&#x-14.;?-2;y.8;&#x'![-;ʂ.;J-2;V.5;&#xJ-20;&#x.900;[email protected]=8;8
G?LAGCFA=FXB=FF:B?�FF=H#"[
NF=JAGCF
J:B?�FB=FF
[email protected][email protected]@:[email protected]:[email protected];[email protected]@:
[email protected]@[email protected]:@OB=F:[email protected][email protected];@[email protected][email protected]@[email protected]:
GCFAJA:[email protected]:[email protected]=8
"[email protected]@K8
[email protected]@:9C8A:@C8DCB=8?F=8:[email protected]=B;@[email protected]
[email protected]?T
?=8WFI
C8A:@CB
(0,9%-
[email protected]:@[email protected]=8CF9
[email protected];F
[email protected]?B=F9'![[email protected]=JL;[email protected]:T
:[email protected]=89;[email protected]:T
C8I?F:8L
0,5
N?:
[email protected]@;
:[email protected]
N?;[email protected]:F
[email protected]?B=F9;@[email protected][email protected]#"[:@D=J
[email protected];[email protected]:?9L
0,05
N?WFI
C8A:@C8
[email protected]:[email protected]:[email protected]#"[:
@A8?T=HB
[email protected]@;A;[email protected]:[email protected]:[email protected]
0,05
N?C8A:@C88DCB=8?F=8
[email protected]@:BA:JLUBE;@=OB=C8OFF
(10
[email protected]?T
[email protected]?J�B==JL
ANBATFI;[email protected]@KFC;F=8KFC8L:;8GF??9CH38=&#x-279;&#x.5:-;ɶ;&#x-5.9;-10;&#x.5G-;ſ-;.1;&#x?-11;&#x.1?9; H-2;q.4;8-2;�.7=;&#x-27.; B=;@:8:@K\BNB
0,1
78BN
A8:9;8GF??9CH:Z8F:[email protected]:@D9FINBCB=FBA;@[email protected]@[email protected]@:
�BCBI
�8A
+?9FIJ�B=F9'![[email protected]:[email protected]
[email protected]@[email protected]:
@[email protected]:@D9GCBD:[email protected][email protected]?BBYWWB;F:[email protected]@IH
[email protected]=B�=89;@[email protected]=8:Y;[email protected]:F?8
[email protected]?T
:CBN9
F=;JK8OFF
NF=GCF;@[email protected]
'=8?FI'![:GCFAJA:[email protected]=8
[email protected]:@[email protected]@EXBAPBNB
�@F:[email protected][email protected]
/[email protected]@DI8;?L�8BA9:;@?F&#x-13.;ʩ-;ɗ.;:-2;u.1;&#x;-15;&#[email protected];.7?;-1;.20;BA:[email protected]@OB=;B'![AJ&#x-13.;:-9;&#x.6B=;&#x-26.;=-1;&#[email protected];.6E;&#x-278;&#[email protected];&#x.6O-;".8; -0.;=-1;.1;;&#x-5B-;ɵ.;'6.;!-7;&#x.7[-;ɱ.;-2;U.4;&#xJ-19;&#x.800;[email protected];8;
=8GC8:[email protected]@:[email protected];OFF
8;FABGB=FBB:[email protected]
'![@GCBDB?9?F:
[email protected]?L=HP:B?F.7;&#x=-9.;H11;&#x.7P-;ɨ.;:17;&#x.3B6;&#x.4?1;.7F;.50;[email protected];[email protected]=B=F9#"[@[email protected][email protected]@I&#x-272;&#x.2F1;.7A;.6;&#xP7.1;&#[email protected];×.5;&#x=0.6;&#[email protected];S-9;&#[email protected];ɇ.;I16;&#x=800;=8B=F9D?9;[email protected]
;@=OB=C8OFF8DCB=8?F=8
";@=�8B?T=HECBIJ?T8GCBDA8:?9?F::FDBACBD=BE
:B?F�[email protected];[email protected]=B=FE#"[:@:[email protected]=B;@=OB=C8OFE8DCB=8?F=8
[email protected];@?T;J
#"[[email protected]@;[email protected]=9TA9:GCFAJA:[email protected]@[email protected]:;8;:[email protected]@[email protected]:HZB=F9
[email protected]=8;@NNF=JA
8;[email protected]=FXB=F9#"[
[email protected]=8;@NG?LA
[email protected]�BBACBD=FP
:B?F�F=J�FH:8?F8;XBFPI=8;
[email protected]@:BA:FBA=8GC8:[email protected]:[email protected]:NH
:HDB?F?F
FG8'![
=8I:8==HB=8NF
[email protected]==HE
[email protected];[email protected]=B=F9#"[@[email protected][email protected]@[email protected]:=9FNB?F
[email protected][email protected]?T=HEI=8;
@[email protected]?B:=BAB=F98DCB=8?F=8I=8&#xT-29;.8G;&#[email protected];&#x.4A1;.6?;&#x-7.7; -26;.1:;&#x-7.1;&#x=-13;&#x.6B-;.8A; =-1;.6F; -25;.98;&#x-17.;=-6;&#x.7CB;&#x-7.8;&#x=-13;&#x.68-;.1?;-10;&#x.7=-;.6;-27;.6I;&#x=-13;&#x.68-;.10;B=F9#"[KH?F=FXB
I=8�B=F9
�BN:;@[email protected]?B
[email protected]:=HE
[email protected]==HE
GCF;@@[email protected][email protected];[email protected]=B=F9#"[@[email protected]:[email protected][email protected]
[email protected]?�[email protected];@[email protected]?T=HEI=8;
@BAT
[email protected]?B:=BAB=F98DCB=8?F=8I=8�B=F9#"[KH?F:HZB
�BN:;@[email protected]?B
=BS8F:=HE
8CB;F:=HE
[email protected]:[email protected]@@;[email protected]=B=F9#"[GCF:=BAB=FF
8DCB=8?F=8:C8I?F�[email protected];@=OB=C8OFF
[email protected]?F�BA:[email protected]:HC8XB=FB'![[email protected]:@?9BFIJ&#x-269;&#x.8F5;&#x.8I8;&#x.1J-;�.80;8TBB:[email protected]:9IF
[email protected]
;@[email protected][email protected]@
W8;@[email protected]@[email protected][email protected]@8=8?FI8
[email protected];8I8B?9NF
P8C8;BCFIJLUFNFWJ=;[email protected]=8?T=HBCBIBC:[email protected]=FIN8
D?9:[email protected]?FF:;?8D8
[email protected][email protected]�BA;@[email protected]@:[email protected]@::@KUJL;[email protected]@9=F9
.: 6
RU2471189C1
@CS8=FIN8
[email protected]=;FABGB=F:[email protected]'![:HDB?F?F
[email protected]:=9CB8;F:[email protected]
GCF
[email protected]:[email protected][email protected][email protected];OFF#"[[email protected]:?F9=FBNC8I?F༓.;ˆ-3;&#xSC8.;ᬖ&#x.7S1;&#x.38O;.4;&#[email protected];&#[email protected];.1E;&#x-251;&#x.7C-;.1B;&.9;-3;;.8;&#xO4.2;༓.;-2;a.9;&#x#11.;"12;&#x.7[-;Ʉ.;G-9;&#[email protected];.4D;&#x-257;&#x.9:7;&#x.2?6;&#x.6F1;.89;.6;&#x=FB2;.9N;&#x-265;&#x.8C8;&#x.187;&#x.2I2;.3?;.6F;.8;[email protected]
[email protected]@[email protected]@I=8&#x-242;&#x.1F1;.1A;&.2;&#xP16.;&#[email protected];&#x.6D1;.1=; .4;&#[email protected];&#xS10.;&#[email protected];G.8;&#xI35.;=08;&.9;[email protected]
1,1
3,0
[email protected]
6,0
[email protected]
#@@:BA:[email protected]
J:B?�FB=FB#"[GCF
[email protected]:[email protected]@[email protected];[email protected]@[email protected]
1,1
5,0
[email protected]
[email protected]
3CFNBC
$AGHJBNHE
[email protected]:[email protected]@GCBDB?B=FB#"[;[email protected]:[email protected]=�B=;@:J4
[email protected][email protected]?T=89#"[[email protected]:F?8
7=8�B=F9'![[email protected]?B=FFFINB=B=F9#"[
[email protected]:[email protected]=8;@=OB=C8OFF
[email protected]?T
?GCF;@=OB=C8OFF8DCB=8?F=8
[email protected]?T
[email protected]:?9L
2, 2, 1, 2, 2
[email protected]@:BA:[email protected]
78:[email protected]
I=8�B=F9'![@;@[email protected]@[email protected];@[email protected]=8
C8:[email protected]
[email protected]?T
GCBDA8:?B=8:CFA
.1.
/8CFAJ=;B
[email protected]=8I8:[email protected]@;@[email protected]@[email protected]
;@[email protected]=8
C8:[email protected]
[email protected]?T
[email protected]@[email protected];?8DH:8BA9I=8©-2;cI4;&#x=8-1;.10;B=FB
'![
[email protected]@[email protected]=8;@=OB=C8OF98DCB=8?F=8
#CBD=FEK8??'![[email protected]:?9B
FG'![[email protected]==HE
ABGB=T
:[email protected]?T=89
(+3),
[email protected]@::GCFAJA:FF8DCB=8?F=8
A=FX8BA9
3CFNBC
$AGHJBN89
[email protected][email protected]?T=89#"[[email protected]:?9B
[email protected]?BF=;JK8OFFA
C8I?F�=HNF;@=OB=C8OF9NF8DCB=8?F=8
[email protected]?T
?I=8�B=F9
'![[email protected]:?9L
9, 10, 11, 12, 12,
[email protected]@:BA:[email protected]
78:[email protected]=8.3T;&#x-274;&#x.8I8;&#x.6=-;ញ&#x.900;B=F9'![@
;@[email protected]@[email protected];@[email protected]=8
C8:[email protected]
[email protected]?T
GCBDA8:?B=8:CFA
.2.
/8CFAJ=;8P
[email protected]=8SC�8WFBA;89I8:[email protected]
[email protected];F:[email protected]@[email protected]:
)@;@[email protected]@[email protected]
;@[email protected]=8
C8:[email protected]
[email protected]?T
[email protected]@[email protected];?8DH:8LA9I=8ਦ.;Y-2;a.5;&#xI25.; =86;&#x.800;B=F9
'![:NN
[email protected]@[email protected]=8
;@=OB=C8OFE8DCB=8?F=8#:[email protected]?T
#CBD=FEK8??'![[email protected]:?9B
-2,8,
FG'![[email protected]==HE
ABGB=T:[email protected]
JNBCB==89
(-2).
[email protected][email protected]�BA;@[email protected]:[email protected]@:JPJDZ8BA9:[email protected]@[email protected]
8SCBS8OFF
+BEA:[email protected][email protected];[email protected]@KIFD8=8C8AA&#[email protected];È-2;e.9;&#[email protected];K-9;&#x.7I1;.7F;&#x-4D1;�.28;&#x-0.4;&#x=-6.;˜-2;v.1;ఐ.;ˆ-1;�.6A;.3; -1.;ကFH:[email protected]=FOBNBXDJACBD=FNF
:B?F�F=8NF'![[email protected]@A?B:@IDBEA:[email protected]:FFF?F:GCFAJA:FF
@KIFD8=8
[email protected]@[email protected]=;[email protected];F:[email protected]@[email protected]:9:[email protected]?BB
[email protected]:=HND?98=8?FI8ö.5;&#x:-0.;=-6;&#x.6H-;.7N;&#x-262;&#x.9D1;�.5?; -24;.98;&#x-10.;=-6;&#x.68?; .5F;&#xI198;&#x-275;&#x.800;[email protected]:AC఑.;ᬀ[email protected]'![[email protected]=F:[email protected]
[email protected]:GCFFIJ.1F;&#x-4.1;&#[email protected];�.4:;&#x-255;&#x.8G-;.2;Ï-2;I.2;IJ9;&#x.700;B=FFDF=8NF;[email protected]@9=F9;[email protected]:F:[email protected]@:@[email protected]:[email protected]
[email protected]
[email protected]@[email protected]@OB=;B:?F9=F9=8A?BDA:B==HPW8;@[email protected]:
[email protected];@?Fɤ.;&#[email protected];.9D;&#x;262;&#[email protected];H.7;&#x?267;&#x.6F2;T.4;BA:[email protected]@OB=;F'![[email protected]
[email protected][email protected]:[email protected]@:[email protected][email protected]@:[email protected]&#[email protected];@EF:@AF
@CS8=FIN8AOB?TLGCBDJGCBXDB=F9ACH:8:[email protected].6;ò.4;BA;@[email protected]=OF8?B
3CBXDB
:[email protected]
[email protected];8A8BA9;@=F=SB=8?FO
[email protected];@@[email protected]@:@XD8LA9
8;F:[email protected]
[email protected]:@EAFABNH
:HIH:8LUFE:[email protected]:;[email protected]:T
[email protected]:HZB==HP;@=OB=C8OFE8DCB=8?F=8
[email protected]
[email protected][email protected]:8=FB8;@[email protected]@[email protected]
[email protected]@;[email protected][email protected][email protected]:
�J8A:JLUFP:[email protected]:[email protected]=F9P
[email protected]:
AD8LUFPY;I8NB=H
[email protected]@I:@?9B:H9:FTSCJGGJ?FO
[email protected][email protected]@[email protected]=HP;C8I:[email protected][email protected];OFF
[email protected]?F�BA:[email protected]=;F
:[email protected]=8DBEA:FB
in vitro
[email protected];[email protected]
[email protected]@[email protected]:[email protected]:@?9B
.: 7
RU2471189C1
[email protected][email protected]@:8T?B&#xT-27;?12;&#x.1B1; BK=HEYWWB;[email protected]@:[email protected]?B:8=F9NFABCDB&#[email protected];|-6;&#[email protected];.7:;&#x-263;&#xJ-26;?12;&#x.1LD;¾-2;V.4; -24;.3I;.4;&#[email protected];.7?;.9B;&#x:8=F;ठ.;NF-;ɖ.;䨒넬.4D;.1;±.8;[email protected]
[email protected]@EAFABNH
)@[email protected]=F9
#[email protected]@[email protected]=;[email protected];F:[email protected]@[email protected]:
:;?L�[email protected]?B=FB
FINB=B=F9A;@[email protected]@[email protected]@:
#"[
@[email protected]@38=�B=;@:J
[email protected]:?F9=FBN
[email protected][email protected];[email protected]@[email protected][email protected];@=OB=C8OFF
[email protected]:[email protected]@
in vitro
:FAA?BDJBNJLOFC8=JL;[email protected]:T
&#x?F00;@?F8LUFEA9BN
�@
;@[email protected]:?9L
[email protected]?T
;@[email protected]=8
[email protected]?T
:I8:[email protected]@=8GC8:[email protected]@;[email protected]=B=FE
[email protected]:[email protected]#"[@;@[email protected][email protected]@I=8".6;ఖ.;&#[email protected];&#x.2?1;.4T;&#[email protected];.2S;&#[email protected];.3I;$.9;&#x=9.5;….8;B=F9:HDB?9LC8I?F&#x-242;&#x.8C6;&#x.782;.2I;$.9;&#x?25.;漒&#x.400;=HBFGH
[email protected]:8=F9
:[email protected]@[email protected]:HZB=F9
;8;[email protected]==HE
[email protected]==HE
[email protected]JA:[email protected]@@;[email protected]=B=F9
;8;8CB8;F:=HE
;@?F�BA:[email protected]=;[email protected];F:[email protected]@[email protected]:
'![
C8AA�FH:8L:[email protected][email protected];[email protected]=B=F9#"[@;@[email protected][email protected]@I=8&#x-14C;&#[email protected];&#x.7?9;&#x.4T-;).6;&#x=-16;&#[email protected]; .5S;&#x-16.;&#[email protected];t.9;&#xI8.7;&#x=-27;&#x.18-;.4;B=F9
GCBDA8:?B==JL::FDBACBD=FPI=8.6;†:6;&#x?5.4;ଥ.;=-1;�.7=;&#xJ6L-;ɢ.;:-2;Y.5;&#x:6F1;.6D;.4B;&#x-250;ਕ.;׆.;鬕&#x.5D1;.6=;&#x-10.;缒&#x.6P-;ə.;I14;&#x.9=8;×B=FE'![
ACBD=FBI�=8B=F9'![C8AA�FH:8L
[email protected]:FS8N:@:[email protected]=B;@=OB=C8OFE8DCB=8?F=8
@OB=;8WJ=;[email protected][email protected]@
[email protected]@[email protected]@:[email protected]:@[email protected]=F:[email protected]'![AJ.7F;&#x-260;&#x.8'2;!20;&#x.4[-;ɓ.;*-2;G.7;&#xJ8.3;[email protected]=8;8
G?LAGCFA=FXB=FF:B?F�F=H#"[
NF=JAGCFJ:B?�FB=FF
[email protected][email protected]@:8=FB
[email protected]:[email protected];[email protected]@:
[email protected]@[email protected]:@OB=F:[email protected][email protected]
NBXDJ;@[email protected][email protected]@[email protected]:GCFAJA:[email protected]:[email protected]=8
.: 8
15
20
25
30
35
40
45
50
RU2471189C1
.: 9

Приложенные файлы

  • pdf 11122393
    Размер файла: 220 kB Загрузок: 0

Добавить комментарий